Pharmacometric and statistical considerations for dose optimization.
Chotsiri P. et al, (2024), CPT Pharmacometrics Syst Pharmacol
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants.
Wattanakul T. et al, (2024), Nat Commun, 15
Medication adherence framework: A population-based pharmacokinetic approach and its application in antimalarial treatment assessments.
Ding J. et al, (2024), CPT Pharmacometrics Syst Pharmacol
Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy Volunteers.
Chotsiri P. et al, (2022), Clin Pharmacol Ther, 112, 824 - 835
A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics.
Wattanakul T. et al, (2022), Expert Rev Clin Pharmacol
Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19.
Assmus F. et al, (2022), Microorganisms, 10
Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2.
Driouich J-S. et al, (2022), EBioMedicine, 82
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial.
Peto TJ. et al, (2022), Lancet Infect Dis, 22, 867 - 878
Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside.
Assmus F. et al, (2022), PLoS Negl Trop Dis, 16
Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity.
Chotsiri P. et al, (2022), Clin Pharmacol Ther, 111, 676 - 685
The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern.
Abdelnabi R. et al, (2022), Nat Commun, 13
Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
Taylor WR. et al, (2021), Malaria Journal, 20
Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria.
Taylor WR. et al, (2021), Malar J, 20
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial (vol 395, pg 1345, 2020)
van der Pluijm RW. et al, (2020), LANCET, 395, 1344 - 1344